Elisa Pedro

421 total citations
47 papers, 308 citations indexed

About

Elisa Pedro is a scholar working on Immunology and Allergy, Rheumatology and Dermatology. According to data from OpenAlex, Elisa Pedro has authored 47 papers receiving a total of 308 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Immunology and Allergy, 17 papers in Rheumatology and 11 papers in Dermatology. Recurrent topics in Elisa Pedro's work include Allergic Rhinitis and Sensitization (21 papers), Food Allergy and Anaphylaxis Research (19 papers) and Urticaria and Related Conditions (16 papers). Elisa Pedro is often cited by papers focused on Allergic Rhinitis and Sensitization (21 papers), Food Allergy and Anaphylaxis Research (19 papers) and Urticaria and Related Conditions (16 papers). Elisa Pedro collaborates with scholars based in Portugal, Paraguay and Spain. Elisa Pedro's co-authors include Maria Conceição Pereira Santos, Rui M. M. Victorino, Ana E. Sousa, Manuel Pereira Barbosa, Manuel Branco Ferreira, Rodrigo Rodrigues Alves, Susana L. Silva, António P. Baptista, Rui S. Soares and Rita Tendeiro and has published in prestigious journals such as PLoS ONE, Journal of Allergy and Clinical Immunology and Allergy.

In The Last Decade

Elisa Pedro

34 papers receiving 301 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Elisa Pedro Portugal 10 122 122 69 68 45 47 308
Manuel Pereira Barbosa Portugal 11 124 1.0× 137 1.1× 96 1.4× 82 1.2× 107 2.4× 49 402
Grant Hayman United Kingdom 9 104 0.9× 35 0.3× 56 0.8× 29 0.4× 20 0.4× 15 219
Irena Krčmová Czechia 11 157 1.3× 81 0.7× 102 1.5× 135 2.0× 6 0.1× 41 363
Elvire Anne Bourgeois France 9 42 0.3× 533 4.4× 44 0.6× 70 1.0× 17 0.4× 9 632
D. Wieczorek Germany 9 161 1.3× 69 0.6× 121 1.8× 59 0.9× 59 1.3× 25 404
Miquel Armengot‐Carbó Spain 8 69 0.6× 18 0.1× 97 1.4× 56 0.8× 7 0.2× 20 280
Charles Mohr Germany 7 165 1.4× 16 0.1× 163 2.4× 28 0.4× 20 0.4× 12 342
Hikotaro Yoshida Japan 9 97 0.8× 25 0.2× 135 2.0× 30 0.4× 10 0.2× 50 306
Natália C. Couto-Francisco United Kingdom 5 441 3.6× 89 0.7× 146 2.1× 241 3.5× 33 0.7× 6 515
Suhail Hadi United States 12 30 0.2× 90 0.7× 185 2.7× 14 0.2× 13 0.3× 22 359

Countries citing papers authored by Elisa Pedro

Since Specialization
Citations

This map shows the geographic impact of Elisa Pedro's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elisa Pedro with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elisa Pedro more than expected).

Fields of papers citing papers by Elisa Pedro

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elisa Pedro. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elisa Pedro. The network helps show where Elisa Pedro may publish in the future.

Co-authorship network of co-authors of Elisa Pedro

This figure shows the co-authorship network connecting the top 25 collaborators of Elisa Pedro. A scholar is included among the top collaborators of Elisa Pedro based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elisa Pedro. Elisa Pedro is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pedro, Elisa, et al.. (2024). Molecular sensitization profile to grass and olive pollens in Portugal. European Annals of Allergy and Clinical Immunology.
2.
Pedro, Elisa, et al.. (2024). Dupilumab in patients with atopic dermatitis: assessing treatment response, clinical features and potential biomarkers in real-life. European Annals of Allergy and Clinical Immunology. 2 indexed citations
3.
Costa, Célia, et al.. (2023). Omalizumab in Chronic Spontaneous Urticaria (CSU): Real-Life Experience in Dose/Interval Adjustments and Treatment Discontinuation. The Journal of Allergy and Clinical Immunology In Practice. 11(8). 2392–2402. 12 indexed citations
4.
Fernandes, Rosa, Cristina Abreu, Célia Costa, et al.. (2023). Controlo a longo prazo da dermatite atópica em doentes sob terapêutica com dupilumab – Um estudo multicêntrico. Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT). 31(1). 31–43.
5.
Pedro, Elisa, et al.. (2023). A real-world characterization of a cohort with eosinophilic esophagitis: looking for severity biomarkers. European Annals of Allergy and Clinical Immunology. 56(6). 252–252. 1 indexed citations
6.
Santos, Maria Conceição Pereira, et al.. (2023). An Unusual IgE-Mediated Hypersensitivity: Two Case Reports of Paracetamol Allergy. Cureus. 15(7). e42240–e42240.
7.
Lorenzo, Cristina de, et al.. (2023). Hypersensitivity to non-steroidal anti-inflammatory drugs on a pediatric Portuguese cohort. European Annals of Allergy and Clinical Immunology. 57(2). 77–77. 3 indexed citations
8.
Ferreira, Manuel Branco, et al.. (2023). Experience of lanadelumab administration in hereditary angioedema: A case series of 4 patients in Portugal. Asia Pacific Allergy. 13(2). 91–94. 4 indexed citations
9.
Costa, Célia, et al.. (2021). Urticaria por frío. Caracterización de la población de una clínica ambulatoria especializada en urticaria. Actas Dermo-Sifiliográficas. 112(8). 740–746. 3 indexed citations
10.
Costa, Célia, et al.. (2021). Cold Urticaria. Characterizing the population from an urticaria outpatient clinic. Actas Dermo-Sifiliográficas. 112(8). 740–746. 1 indexed citations
11.
Pedro, Elisa, et al.. (2019). Biomarcadores de sensibilização primária e reatividade cruzada em doentes alérgicos a veneno de himenópteros. Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT). 27(2). 1 indexed citations
12.
Moreira, Susana, et al.. (2019). Contribution of In Vivo and In Vitro Testing for The Diagnosis of Local Allergic Rhinitis. Journal of Investigational Allergology and Clinical Immunology. 29(1). 46–48. 17 indexed citations
13.
Mendes, Ana, et al.. (2016). Treatment of Severe Atopic Dermatitis with Omalizumab: Experience of a Portuguese Immunoallergology Department. Journal of Allergy and Clinical Immunology. 137(2). AB149–AB149. 1 indexed citations
14.
Silva, Sara Pereira da, et al.. (2013). Estudo comparativo de métodos de rastreio de atopia em doentes com rinite (ImmunoCAP® Rapid versus Phadiatop® e testes cutâneos em picada). Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT). 21(1). 41–47. 1 indexed citations
15.
Silva, Pedro, et al.. (2012). Omalizumab in the treatment of allergic asthma: Experience in our Immunoallergology Department. 20(4). 263–271. 1 indexed citations
16.
Pedro, Elisa, et al.. (2008). Anillos vasculares completos. Anales de Pediatría. 69(1). 52–55. 4 indexed citations
17.
Baptista, António P., Rodrigo Rodrigues Alves, Rui S. Soares, et al.. (2007). Expansion of circulating Foxp3+CD25bright CD4+ T cells during specific venom immunotherapy. Clinical & Experimental Allergy. 38(2). 291–297. 58 indexed citations
18.
Santos, Maria Conceição Pereira, et al.. (2005). Immunoblot studies in allergic patients to hymenoptera venom before and during immunotherapy.. PubMed. 37(7). 273–8. 9 indexed citations
19.
Santos, Maria Conceição Pereira, et al.. (2001). Specific immunotherapy with hymenoptera venom. 1(3-4). 249–253. 1 indexed citations
20.
Ferreira, Manuel Branco, et al.. (1998). Ascites in hereditary angioedema. Allergy. 53(5). 543–545. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Manuel Pereira Barbosa Breakdown of academic impact, for papers by Grant Hayman Breakdown of academic impact, for papers by Irena Krčmová Breakdown of academic impact, for papers by Elvire Anne Bourgeois Breakdown of academic impact, for papers by D. Wieczorek Breakdown of academic impact, for papers by Miquel Armengot‐Carbó Breakdown of academic impact, for papers by Charles Mohr Breakdown of academic impact, for papers by Hikotaro Yoshida Breakdown of academic impact, for papers by Natália C. Couto-Francisco Breakdown of academic impact, for papers by Suhail Hadi
Rankless by CCL
2026